Cadrenal Therapeutics, Inc. Common Stock
CVKD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$10,651 | -$8,357 | -$6,714 |
| Dep. & Amort. | $2 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $1,419 | $710 | $0 |
| Change in WC | $1,873 | $144 | $608 |
| Other Non-Cash | -$0 | $3,970 | $4,901 |
| Operating Cash Flow | -$7,358 | -$3,530 | -$1,205 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$7 | -$3 | $0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$2 |
| Inv. Sales/Matur. | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$7 | -$3 | -$2 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | -$250 | $0 |
| Stock Issued | $5,144 | $11,903 | $1,240 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $3,836 | $250 | $0 |
| Financing Cash Flow | $8,980 | $11,903 | $1,240 |
| Forex Effect | $0 | $0 | -$0 |
| Net Chg. in Cash | $1,615 | $8,370 | $33 |
| Supplemental Information | – | – | – |
| Beg. Cash | $8,403 | $33 | $0 |
| End Cash | $10,018 | $8,403 | $33 |
| Free Cash Flow | -$7,364 | -$3,534 | -$1,205 |